Search the Newsreel

Earnings call transcript: Amagi Media Labs posts strong Q1 2026 growth

Bodhi Tree Multimedia consolidated net profit rises 46.51% in the June 2026 quarter

SBC Medical Reports 13 Pct Rise In Q2 Revenue, Net Income Jumps 335 Pct

SBC Medical Group Holdings Inc. reported a 13% year-on-year increase in consolidated revenue to US$49 million for Q2 fiscal 2026, with net income surging by 335% to US$11 million. The company attributes this growth to strengthening underlying fundamentals, including the integration of healthcare and …

Medico Remedies standalone net profit rises 38.46% in the June 2026 quarter

Trump Media's CFO Sells Nearly 20,000 Shares After the Company's Crypto Business Combination Collapsed

Key Points The transaction involved 18,817 shares at a weighted average price of $8.33 per share, representing a total value of ~$157,000 on August 13, 2026. The move reduced the executive's direct equity holdings by 3% while maintaining a total beneficial position of ~582,000 …

MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates

MediciNova (MNOV) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss and improving from a $0.07 loss a year ago. The company also exceeded revenue estimates, posting $0.46 million against a $0.15 million consensus, though its …

OUTFRONT Media (OUT), What Is Behind Its Latest Attention?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why OUTFRONT Media's latest earnings and deals matter for investors OUTFRONT Media (OUT) has been in focus after reporting second quarter 2026 results, raising …

ICU Medical (ICUI) investor to sell 5,417 shares worth $982K on NASDAQ

ICU Medical shareholder Daniel Woolson plans to sell 5,417 shares of common stock, valued at $982,264.61, on NASDAQ by August 13, 2026. This sale follows a previous transaction three months prior where Woolson sold 2,123 shares for $280,684.80. The shares originate from various performance …

Parabilis Medicines (PBLS) Earnings Date and Reports 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com

The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.

Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000

Parabilis Medicines, Inc. (PBLS) reported its Q2 revenue as $148,000. The company, a clinical-stage biopharmaceutical firm, focuses on developing transformative medicines for "undruggable" protein targets using its proprietary Helicon platform. Analysts currently have a "BUY" consensus for PBLS with an average target price of …

Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance

Earnings Call Insights: Tenon Medical (TNON) Q2 2026 MANAGEMENT VIEW * "Second quarter revenue was $1.3 million, an increase of 127% over the second quarter last year, and gross profit was $0.8 million, an increase of 232% over the prior year period." (CEO, President …

MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results

MediciNova (NASDAQ:MNOV) exceeded quarterly earnings expectations, reporting a loss of $0.05 per share against an estimated $0.06 loss, and revenues of $0.46 million, significantly above the $0.07 million forecast. Despite the positive earnings surprise, the company experienced a slight dip in share price to …

MediWound (NASDAQ:MDWD) Issues Earnings Results

Tenon Medical earnings missed by $3.95, revenue fell short of estimates

Medical Properties Trust declares $0.09 quarterly dividend

Medical Properties Trust Inc. announced a quarterly cash dividend of $0.09 per share of common stock. This dividend will be distributed on October 8, 2026, to shareholders recorded as of September 10, 2026. The company operates as a real estate investment trust focusing on …

MediciNova: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for MediciNova. No further details are available in the provided content.

CorMedix Inc. Q2 2026 Earnings Call Summary

CorMedix Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Commercial Expansion Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. …

ICU Medical (ICUI) Q2 2026 Earnings Call Transcript

AK Medical Sets August Board Meeting to Review Interim Results and Dividend

Insider Stock Buying Reaches CN¥264.4m On Shanghai INT Medical Instruments

ICU Medical VP Daniel Woolson sells $982,264 in stock

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc. (NASDAQ:ICUI), sold 5,417 shares of the company's common stock for $982,264 on August 13, 2026, at $181.33 per share. This sale occurred as ICUI shares are near their 52-week high, following strong Q2 results where …

Profound Medical (PROF) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer and Chairman - Arun Swarup MenawatPresident - Mathieu BurtnykChief Commercial Officer - Tom TamberrinoCorporate Controller - Matthew SobczykInvestor Relations - Stephen Kilmer TAKEAWAYS Revenue -- …

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Corporate Communications - Ben Atkins President and Chief Executive Officer - Cary G. Vance Chief Financial Officer - David O'Toole Need a …

Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow ...

ICU Medical (ICUI) officer Daniel Woolson sells 5,417 shares at $181.33

Daniel Woolson, VP and GM-Infusion Capital at ICU Medical Inc. (ICUI), sold 5,417 shares of common stock at $181.33 per share on August 13, 2026. After this transaction, Woolson directly holds 17,062 shares of ICU Medical common stock. The sale was not conducted under …

Earnings call transcript: Tenon Medical posts strong growth in Q2 2026

Tenon Medical reported strong revenue growth of 127% year-over-year in Q2 2026, reaching $1.3 million, but still posted a wider net loss of $4.1 million and missed analyst expectations for both revenue and earnings. Despite the financial miss, the company saw significant gross margin …

MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027

MediciNova (MNOV) reported a revenue increase to $0.5M in Q2 2026, primarily from Mayo ALS study services, while significantly narrowing its net loss to $2.3M. Research and development expenses decreased year-over-year, and the company's $25.4M in cash reserves are projected to fund operations until …

Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75

Strata Critical Medical, Inc. director Reginald Love sold 5,091 shares of Class A common stock at $5.75 per share on August 10, 2026. Following this transaction, his direct holdings in the company amount to 146,481 shares. The sale was reported in an open market …

What's Going On With Glacier Media Inc. Stock Thursday?

Adagio Medical Highlights VT Ablation Progress in Presentation

Modern Chinese Medicine Group Sets August Board Meeting for Interim Results and Dividend Review

Farallon funds disclose 13.6M-share RVMD stake in Schedule 13G/A filing

Farallon Capital Management, L.L.C. and its affiliated funds have disclosed a beneficial ownership of 13,564,149 shares, or 6.4%, of Revolution Medicines, Inc. (RVMD) common stock, according to a recent Schedule 13G/A filing. This includes 13,550,796 shares and 120,085 common stock purchase warrants, with the …

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Tenon Medical, Inc. 2Q 2026: Revenue $1.279M, Net loss $(4.05M), EPS $(12.35) — 10-Q Summary

Tenon Medical, Inc. reported its second-quarter 2026 results, showing revenue of $1.279 million, a net loss of $(4.05 million), and a diluted loss per share of $(12.35). Revenue more than doubled year-over-year, driven by increased procedure volumes and the acquisition of the SImmetry+ System. …